期刊文献+

代谢综合征患者发生肾损害的危险因素 被引量:4

下载PDF
导出
摘要 目的:探讨代谢综合征(MS)患者肾损害的临床特点及危险因素。方法:选取2012年5-7月在广州市南沙中心医院内科住院的代谢综合征患者。统计肾损害的患病率及临床特征,分析发生肾损害的危险因素。结果:133例MS患者中有62例发生肾损害(46.62%),肾损害组女性所占比例较多,年龄较大,SBP、MAP、FPG、UA均较非肾损害组偏高,BMI低于非肾损害组。年龄、MAP、FPG、UA为发生肾损害的危险因素,其OR值分别为1.035、1.019、1.091和1.005,P值均<0.01。结论:代谢综合征患者肾损害的发生率高,年龄、MAP、FPG、UA为发生肾损害的危险因素。
出处 《中外医学研究》 2013年第18期126-127,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献6

  • 1Coresh J, Astor B C, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey[J]. Am J Kidney Dis, 2003, 41(1): 1-12.
  • 2Zhang L, Wang F, Wang L, et al.Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet, 2012, 379(9818): 815-822.
  • 3Chen J, Muntner P, Hamm L L, et al.The metabolic syndrome and chronic kidney disease in US adults[J].Ann Intern Med, 2004, 140(3): 167-174.
  • 4Wad H J.Uric acid as independent risk factor in the treatment of hypertension[J].Lancet, 1998, 352(1): 670-671.
  • 5Marilda Mazzali, John Kanellis, Lin Han, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism[J].Am J Physiol Renal Physiol, 2002, 282(3): 991-997.
  • 6张路霞,左力,徐国宾,王芳,王淑玉,王梅,吕继成,张军茹,刘力生,王海燕.北京市石景山地区中老年人群中慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2006,22(2):67-71. 被引量:369

二级参考文献15

  • 1张路霞,王梅,王海燕.慢性肾脏病的流行病学研究[J].中华肾脏病杂志,2005,21(7):425-428. 被引量:69
  • 2Xue JL,Ma JZ,Louis TA,et al.Forecast of the number of patients with end-stage renal disease in the United States to the year 2010.J Am Soc Nephrol,2001,12:2753-2758.
  • 3Coresh J,Astor BC,Green T,et al.Prevalence of Chronic Kidney Disease and Decreased Kidney Function in the Adult US Population:Third National Health and Nutrition Examination Survey.Am J Kidney Dis,2003,41:1-12.
  • 4Chobanian AV,Bakris GL,Black HR,et al.The Seventh Report of the Joint National Committee on prevention,detection,evaluation and treatment of high blood pressure.JAMA,2003,21:2560-2572.
  • 5Anonymous.KDOQI clinical practice guidelines for chronic kidney disease:evaluation,classification,and stratification.Kidney Disease Outcome Quality Initiative.Am J Kidney Dis,2002,39 Suppl 2:S1-S246.
  • 6Chadban SJ,Briganti EM,Kerr PG,et al.Prevalence of kidney damage in Australian adults:the AusDiab kidney study.J Am Soc Nephrol,2003,14:S131-S138.
  • 7Garg AX,Kiberd BA,Clark WF,et al.Albuminuria and renal insufficiency prevalence guides population screening:results form the NHANESⅢ.Kidney Int,2002,61:2165-2175.
  • 8Ramirez SP,Mcclellan W,Port FK,et al.Risk factors for proteinuria in a large,multiracial,southeast Asian population.J Am Soc Nephrol,2002,13:1907-1917.
  • 9Levey AS,Eckardt KU,Tsukamoto Y,et al.Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO).Kidney Int,2005,67:2089-2100.
  • 10Zuo L,Ma YCH,Wang M,et al.Application of glomerular giltration rate estimating euqtions in Chinese patients with chronic kidney disease.Am J Kidney Dis,2005,45:463-472.

共引文献368

同被引文献47

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部